These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 1221749

  • 21. Changing paradigm of prophylaxis with longer acting factor concentrates.
    Carcao M.
    Haemophilia; 2014 May; 20 Suppl 4():99-105. PubMed ID: 24762284
    [Abstract] [Full Text] [Related]

  • 22. Haemophilia part 1: an introduction.
    Khair K.
    Br J Nurs; 2014 May; 22(11):620. PubMed ID: 23899729
    [No Abstract] [Full Text] [Related]

  • 23. [Clinical evaluation of factors VIII and IX manufactured in Hungary, based on results of the first half year].
    Nemes L, Ceglédi A, Szabó G, Varga M, Sas G.
    Orv Hetil; 1998 Mar 29; 139(13):749-52. PubMed ID: 9578703
    [Abstract] [Full Text] [Related]

  • 24. The modern treatment of haemophilia: a narrative review.
    Franchini M.
    Blood Transfus; 2013 Apr 29; 11(2):178-82. PubMed ID: 22790275
    [No Abstract] [Full Text] [Related]

  • 25. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul 15; 153(2):147-57. PubMed ID: 7600466
    [Abstract] [Full Text] [Related]

  • 26. The current status of prophylactic replacement therapy in children and adults with haemophilia.
    Ljung R, Gretenkort Andersson N.
    Br J Haematol; 2015 Jun 15; 169(6):777-86. PubMed ID: 25819695
    [Abstract] [Full Text] [Related]

  • 27. A guide for home treatment--Madrid 1978.
    Scand J Haematol Suppl; 1980 Jun 15; 35():1-27. PubMed ID: 6770457
    [No Abstract] [Full Text] [Related]

  • 28. Hemophilia: a guide for the primary care physician.
    Eyster ME.
    Postgrad Med; 1978 Nov 15; 64(5):75-82. PubMed ID: 714837
    [Abstract] [Full Text] [Related]

  • 29. Self-therapy for haemophilia in Norway. Effect on transfusion frequency and days lost from work.
    Evensen SA, Thaule R, Grøan K.
    Acta Med Scand; 1979 Nov 15; 205(5):395-9. PubMed ID: 443078
    [Abstract] [Full Text] [Related]

  • 30. Hemophilia management in transfusion medicine.
    Poon MC, Card R.
    Transfus Apher Sci; 2012 Jun 15; 46(3):299-307. PubMed ID: 22503305
    [Abstract] [Full Text] [Related]

  • 31. Jaundice and hepatitis B antigen-antibody in hemophilia.
    Lewis JH, Maxwell NG, Brandon JM.
    Transfusion; 1974 Jun 15; 14(3):203-11. PubMed ID: 4835949
    [No Abstract] [Full Text] [Related]

  • 32. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort.
    Gaboulaud V, Parquet A, Tahiri C, Claeyssens S, Potard V, Faradji A, Peynet J, Costagliola D, Suivi Thérapeutique National des Hémophiles Group.
    Br J Haematol; 2002 Feb 15; 116(2):383-9. PubMed ID: 11841442
    [Abstract] [Full Text] [Related]

  • 33. Joint WFH-ISTH session: issues in clinical trial design.
    Peyvandi F, Farrugia A, Iorio A, Key NS, Srivastava A.
    Haemophilia; 2014 May 15; 20 Suppl 4():137-44. PubMed ID: 24762289
    [Abstract] [Full Text] [Related]

  • 34. Activated F IX concentrate (FEIBA) used in the treatment of haemophilic patients with antibody to F VIII.
    Stenbjerg S, Jørgensen J.
    Acta Med Scand; 1978 May 15; 203(6):471-6. PubMed ID: 665313
    [Abstract] [Full Text] [Related]

  • 35. The haemophiliac in the eighties. Workshop II: Mobilizing support for haemophilia care.
    Haemostasis; 1981 May 15; 10 Suppl 1():51-79. PubMed ID: 6790371
    [No Abstract] [Full Text] [Related]

  • 36. Haemophilia management in New Zealand: an Auckland perspective.
    Ockelford PA, Benny AG, Van de Water NS, Berry EW.
    N Z Med J; 1989 Apr 26; 102(866):189-91. PubMed ID: 2496366
    [No Abstract] [Full Text] [Related]

  • 37. Prophylaxis for hemophilia: state of the art or state of confusion?
    Gruppo RA.
    J Pediatr; 1998 Jun 26; 132(6):915-7. PubMed ID: 9627577
    [No Abstract] [Full Text] [Related]

  • 38. [Results of a cooperative programme of profilactic treatment for haemophilia A and B (author's transl)].
    Sangre (Barc); 1978 Jun 26; 23(5B):780-92. PubMed ID: 725718
    [No Abstract] [Full Text] [Related]

  • 39. Haemophilia.
    Biggs R.
    Proc R Soc Med; 1969 Sep 26; 62(9):913-4. PubMed ID: 4241884
    [No Abstract] [Full Text] [Related]

  • 40. [Efficacy of factor 8 rich cryoproteins in the treatment of hemophilia].
    Vergoz D, Combrisson A, Vialette T, André R.
    Transfusion (Paris); 1967 Sep 26; 10(1):3-10. PubMed ID: 6048649
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.